🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the REaCT-Vascular Access Her2 negative study, the investigator will use...
Status
Completed
Location
The Ottawa Hospital Cancer Centre
Start Date
2016-04
Trial ID
NCT02688998
Treatments Being Tested
1. In this study, the risk factors leading to catheter-related complication...
Status
Completed
Location
Qianfoshan Hospital
Start Date
2022-07-28
Trial ID
NCT05643937
Treatments Being Tested
The Ministry of Health Malaysia designs an education program for diabetes m...
Status
Completed
Location
Klinik Kesihatan Daro
Start Date
2023-05-01
Trial ID
NCT05106231
Treatments Being Tested
This study prospectively investigates the safety, FVIII immunogenicity, and...
Status
Withdrawn
Location
Children's Hospital Los Angeles
Start Date
2022-02-17
Trial ID
NCT04030052
Treatments Being Tested
Introduction: The placement of a peripheral inserted central catheter (PICC...
Status
Completed
Location
Hospital Dr. Josep Trueta de Girona
Start Date
2023-12-01
Trial ID
NCT06135857
Treatments Being Tested
The aim of the study was to compare the efficacy of body stabilization exer...
Status
Unknown
Location
Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Start Date
2019-03-01
Trial ID
NCT03857698
Treatments Being Tested
In this study, color Doppler ultrasound diagnostic instrument and electroni...
Status
Completed
Location
Qianfoshan Hospital
Start Date
2022-07-10
Trial ID
NCT05638048
In the REaCT-Vascular Access Trastuzumab study (REaCT-VA), the investigator...
Status
Completed
Location
The Ottawa Hospital Cancer Centre
Start Date
2016-04
Trial ID
NCT02632435
The aim of our study is to examine the effect of using kinesiology tape and...
Status
Completed
Location
Üsküdar Unıversıty
Start Date
2023-09-01
Trial ID
NCT06004271
Treatments Being Tested